A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Clinical trial NCT02272855 · COMPLETED
Trial details
- NCT number
- NCT02272855
- Sponsor
- Takara Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-30
- Primary completion
- 2016-10-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.